Sandy Lipkins is a seasoned executive with over three decades of experience in venture capital, finance, and business development, with a strong focus on the healthcare sector. He has built a distinguished career driving growth across the anti-aging, wellness, and regenerative medicine industries. Sandy has played a key role in the advancement of stem cell therapies and tissue banking, leveraging an extensive network and deep industry knowledge.
His leadership in biologics manufacturing, compounding, and commercial strategy has helped scale innovative companies from inception to profitability and successful exit. With a passion for bringing advanced health solutions to a wider audience, both in the U.S. and abroad, Sandy is committed to expanding access to cutting-edge regenerative technologies. His track record includes guiding companies through every phase—from startup to revenue growth and eventual acquisition or other liquidity events.